Definitive Healthcare (DH) Earnings Analysis
Definitive Healthcare (DH) next reports earnings on 2026-08-06, consensus EPS 0.04 USD. Last quarter (2026-05-07) it beat with EPS 0.06 USD vs 0.03 USD est (+100%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E -0.43.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does DH next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.04 USD |
| Revenue estimate | 0.06B |
DH earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.06 USD | 0.03 USD | +100% | Beat |
| 2026-02-26 | 0.06 USD | 0.06 USD | 0% | Beat |
| 2025-11-06 | 0.07 USD | 0.06 USD | +16.7% | Beat |
| 2025-08-07 | 0.07 USD | 0.05 USD | +40% | Beat |
| 2025-05-08 | 0.05 USD | 0.02 USD | +150% | Beat |
| 2025-02-27 | 0.08 USD | 0.07 USD | +14.3% | Beat |
| 2024-08-05 | 0.09 USD | 0.09 USD | 0% | Beat |
Beat rate: 7/7 (100%) over reported quarters with consensus data.
DH valuation and analyst view
| Trailing P/E | -0.43 |
|---|---|
| Trailing EPS | -1.62718 USD |
| Price / book | 0.50 |
| Dividend yield | 0.00% |
| Market cap | 0.07B |
| Analyst consensus | Hold (3 buy / 9 hold / 3 sell) |
| Avg price target | 1.1 USD |
Related research pages
Frequently asked questions
When is Definitive Healthcare (DH)'s next earnings date?
Definitive Healthcare is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.04 USD and revenue estimate of 0.06B.
Did DH beat earnings last quarter?
In its 2026-05-07 report, DH posted EPS of 0.06 USD versus a 0.03 USD estimate — a beat of 100%.
What is DH's earnings track record?
Over the last 7 reported quarters with consensus data, DH beat estimates 7 times (100%).
What is DH's current P/E ratio and EPS?
DH trades at a trailing P/E of -0.43 on trailing EPS of -1.6271783076367334 USD.
What do analysts rate DH?
Analyst consensus is "Hold" across 15 ratings (0 strong buy, 3 buy, 9 hold, 3 sell, 0 strong sell). Average 12-month price target: 1.1 USD.